- Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy2023 | First Faculty of Medicine, Faculty of Science, Second Faculty of Medicine
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy2017 | First Faculty of Medicine
- Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy2010 | Third Faculty of Medicine